Logo image of ADK.CA

DIAGNOS INC (ADK.CA) Stock Fundamental Analysis

TSX-V:ADK - TSX Venture Exchange - CA2524423068 - Common Stock - Currency: CAD

0.315  +0 (+0.8%)

Fundamental Rating

0

ADK gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 6 industry peers in the Health Care Technology industry. ADK has a bad profitability rating. Also its financial health evaluation is rather negative. ADK is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ADK had negative earnings in the past year.
In the past year ADK has reported a negative cash flow from operations.
In the past 5 years ADK always reported negative net income.
In the past 5 years ADK always reported negative operating cash flow.
ADK.CA Yearly Net Income VS EBIT VS OCF VS FCFADK.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -1M -2M -3M

1.2 Ratios

ADK has a worse Return On Assets (-117.56%) than 71.43% of its industry peers.
Industry RankSector Rank
ROA -117.56%
ROE N/A
ROIC N/A
ROA(3y)-313.58%
ROA(5y)-236.98%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ADK.CA Yearly ROA, ROE, ROICADK.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10K 20K 30K 40K 50K

1.3 Margins

ADK does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ADK.CA Yearly Profit, Operating, Gross MarginsADK.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

More info and screens

1

2. Health

2.1 Basic Checks

ADK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ADK has been increased compared to 1 year ago.
The number of shares outstanding for ADK has been increased compared to 5 years ago.
Compared to 1 year ago, ADK has a worse debt to assets ratio.
ADK.CA Yearly Shares OutstandingADK.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ADK.CA Yearly Total Debt VS Total AssetsADK.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M

2.2 Solvency

ADK has an Altman-Z score of -17.21. This is a bad value and indicates that ADK is not financially healthy and even has some risk of bankruptcy.
ADK has a Altman-Z score of -17.21. This is comparable to the rest of the industry: ADK outperforms 42.86% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -17.21
ROIC/WACCN/A
WACC9.17%
ADK.CA Yearly LT Debt VS Equity VS FCFADK.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M

2.3 Liquidity

A Current Ratio of 0.95 indicates that ADK may have some problems paying its short term obligations.
ADK's Current ratio of 0.95 is in line compared to the rest of the industry. ADK outperforms 57.14% of its industry peers.
A Quick Ratio of 0.95 indicates that ADK may have some problems paying its short term obligations.
ADK's Quick ratio of 0.95 is in line compared to the rest of the industry. ADK outperforms 57.14% of its industry peers.
Industry RankSector Rank
Current Ratio 0.95
Quick Ratio 0.95
ADK.CA Yearly Current Assets VS Current LiabilitesADK.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

More info and screens

0

3. Growth

3.1 Past

ADK shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.50%.
ADK shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -35.13%.
Measured over the past years, ADK shows a very negative growth in Revenue. The Revenue has been decreasing by -12.22% on average per year.
EPS 1Y (TTM)-2.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.22%
Revenue 1Y (TTM)-35.13%
Revenue growth 3Y-13.95%
Revenue growth 5Y-12.22%
Sales Q2Q%-50.12%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-0.49%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.67%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ADK.CA Yearly Revenue VS EstimatesADK.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M 2M 2.5M
ADK.CA Yearly EPS VS EstimatesADK.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -0.01 -0.02 -0.03 -0.04 -0.05

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ADK. In the last year negative earnings were reported.
Also next year ADK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ADK.CA Price Earnings VS Forward Price EarningsADK.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ADK.CA Per share dataADK.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.01 -0.02 -0.03 -0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ADK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DIAGNOS INC

TSX-V:ADK (3/7/2025, 7:00:00 PM)

0.315

+0 (+0.8%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)02-26 2025-02-26
Earnings (Next)07-15 2025-07-15
Inst Owners0.01%
Inst Owner ChangeN/A
Ins Owners5.86%
Ins Owner ChangeN/A
Market Cap31.84M
Analysts84.44
Price Target1.53 (385.71%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-63.64%
Min Revenue beat(2)-64.4%
Max Revenue beat(2)-62.88%
Revenue beat(4)0
Avg Revenue beat(4)-58.83%
Min Revenue beat(4)-64.4%
Max Revenue beat(4)-47.62%
Revenue beat(8)0
Avg Revenue beat(8)-52.78%
Revenue beat(12)1
Avg Revenue beat(12)-43.03%
Revenue beat(16)2
Avg Revenue beat(16)-37.85%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 249.92
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -117.56%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-313.58%
ROA(5y)-236.98%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 10.26%
Cap/Sales 10.36%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.95
Quick Ratio 0.95
Altman-Z -17.21
F-Score4
WACC9.17%
ROIC/WACCN/A
Cap/Depr(3y)20.66%
Cap/Depr(5y)24.46%
Cap/Sales(3y)6.15%
Cap/Sales(5y)7.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.22%
EPS Next Y-0.49%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-35.13%
Revenue growth 3Y-13.95%
Revenue growth 5Y-12.22%
Sales Q2Q%-50.12%
Revenue Next Year4.67%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-24.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year66.62%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-45.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-45.63%
OCF growth 3YN/A
OCF growth 5YN/A